29 results
425
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
18 Dec 23
Business combination disclosure
6:02am
“The Merger—Background of the Merger” is amended and restated by replacing it with the following:
On February 10, 2023, Cyclo entered into an engagement … completed its work for Cyclo in July 2023 and this engagement letter was terminated on September 14, 2023, with the indemnification provisions
8-K
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
18 Dec 23
Other Events
6:01am
“The Merger—Background of the Merger” is amended and restated by replacing it with the following:
On February 10, 2023, Cyclo entered into an engagement … completed its work for Cyclo in July 2023 and this engagement letter was terminated on September 14, 2023, with the indemnification provisions
424B3
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
21 Nov 23
Prospectus supplement
9:15am
to support the initiation or continuation of clinical trials;
delays in confirming target engagement, biomarkers, patient selection, or other relevant … .
On February 10, 2023, Cyclo entered into an engagement letter with MTS to assist in identifying potential licensing, merger and other strategic opportunities
S-4/A
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
20 Nov 23
Registration of securities issued in business combination transactions (amended)
8:50am
or continuation of clinical trials;
delays in confirming target engagement, biomarkers, patient selection, or other relevant criteria to be utilized … into an engagement letter with MTS to assist in identifying potential licensing, merger and other strategic opportunities. Cyclo was not required
S-4
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
7 Nov 23
Registration of securities issued in business combination transactions
4:45pm
or continuation of clinical trials;
delays in confirming target engagement, biomarkers, patient selection, or other relevant criteria to be utilized … Price Requirement.
On February 10, 2023, Cyclo entered into an engagement letter with MTS to assist in identifying potential licensing, merger and other
425
EX-2.1
81pnu9k4ehl5c6la
21 Sep 23
Business combination disclosure
4:28pm
8-K
EX-2.1
xeu crmf60
21 Sep 23
Cyclo Therapeutics, Inc. and Applied Molecular Transport Inc. Enter into a Definitive Merger Agreement
4:28pm
8-K
EX-1.1
lw05z
11 Dec 20
Cyclo Therapeutics Announces Pricing of $12.5 Million Public Offering
4:02pm
424B4
59u90yv
11 Dec 20
Prospectus supplement with pricing info
1:38pm
424B4
eagy2t nhz9vn93m9uk3
11 Dec 20
Prospectus supplement with pricing info
12:00am
8-K
EX-10.2
dgwu8p
4 Jun 19
CTD Holdings Announces $7.2 Million Private Placement
12:00am
8-K
g9765mzxv8ll70nqo
25 Apr 18
Unregistered Sales of Equity Securities
4:01pm
8-K
8c0dezewf577ljv8cxre
20 Oct 17
Unregistered Sales of Equity Securities
12:00am